Clinical Research Directory

Drug-Drug Interaction (DDI) Study of Leramistat in Healthy Adult Subjects

Sponsor: Modern Biosciences Ltd

Summary

A DDI study consisting of 4 parts conducted as an open label, fixed sequence study in healthy adult subjects.

Official title: A Phase 1, Open-label, 4-Part, Drug-Drug Interaction Study to Evaluate the Effects of Inhibition and Induction of CYP3A4 on the Pharmacokinetics of Leramistat, to Assess the Effect of Leramistat on the Pharmacokinetics of Simvastatin, and to Evaluate the Pharmacokinetic Interaction Between Leramistat and Upadacitinib (RINVOQ®) in Healthy Adult Subjects

Key Details

Conditions

Interventions

Locations (1)